Sayfa yüklenirken bir hata oluştu.
Teknik ekibimiz bilgilendirildi, ancak sorunun devam etmesi durumunda lütfen e-posta destek widget ile bize ulaşın.
| Trend | Peers | Company |
|---|---|---|
| Is return on equity increasing? | Yes | Yes |
| Is net profit margin increasing? | Yes | Yes |
| Is asset turnover increasing? | Yes | Yes |
| Is equity multiplier increasing? | Yes | Yes |
| Competitors Used |
|---|
| AstraZeneca PLC |
| Johnson & Johnson |
| Perrigo Company plc |
| Sandoz Group AG |
| Novartis AG |
| Return on Equity Benchmarks | ||||||||
| Comparable Companies | ||||||||
| AZN | 0R34 | 0Y5E | 0SAN | 0QLR | H6D0 | |||
| Return On Equity | ||||||||
| Latest Twelve Months | 20% | 34% | -1% | 3% | 33% | 9% | ||
| Fiscal Year - 1 | 16% | 18% | 0% | 1% | 16% | 6% | ||
| Fiscal Year - 2 | 9% | 22% | -3% | 10% | 10% | 5% | ||
| Fiscal Year - 3 | 0% | 26% | -2% | 11% | 37% | 5% | ||
| Fiscal Year - 4 | 22% | 24% | 1% | 6% | 14% | 4% | ||
| Fiscal Year - 5 | 10% | 25% | 3% | NA | 11% | 2% | ||
| Average | 13% | 25% | 0% | 6% | 20% | 5% | ||
| Median | 13% | 25% | -1% | 6% | 15% | 5% | ||
| Benchmarks | Ticker | |||||||
| AstraZeneca PLC | LSE:AZN | |||||||
| Johnson & Johnson | LSE:0R34 | |||||||
| Perrigo Company plc | LSE:0Y5E | |||||||
| Sandoz Group AG | LSE:0SAN | |||||||
| Novartis AG | LSE:0QLR | |||||||
| Financial Performance | ||||||||
| Comparable Companies | ||||||||
| (in millions) | AZN | 0R34 | 0Y5E | 0SAN | 0QLR | H6D0 | ||
| Latest Fiscal Year | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | ||
| LTM Period | Jun-25 | Sep-25 | Jun-25 | Jun-25 | Sep-25 | Jun-25 | ||
| Revenues | ||||||||
| Latest Twelve Months | 56,501 | 92,149 | 4,326 | 10,587 | 56,372 | 11,019 | ||
| Fiscal Year | 54,073 | 88,821 | 4,373 | 10,384 | 51,722 | 11,233 | ||
| Fiscal Year - 1 | 45,811 | 85,159 | 4,656 | 9,979 | 46,660 | 11,302 | ||
| Fiscal Year - 2 | 44,351 | 79,990 | 4,452 | 9,306 | 43,461 | 10,858 | ||
| Fiscal Year - 3 | 37,417 | 78,740 | 4,139 | 9,678 | 43,974 | 9,545 | ||
| Fiscal Year - 4 | 26,617 | 82,584 | 4,088 | 9,658 | 49,898 | 9,892 | ||
| Fiscal Year - 5 | 24,384 | 82,059 | 3,870 | NA | 48,677 | 8,480 | ||
| Net Income | ||||||||
| Latest Twelve Months | 8,295 | 25,119 | (60) | 227 | 14,393 | 1,522 | ||
| Fiscal Year | 7,035 | 14,066 | (161) | 0 | 11,941 | 1,442 | ||
| Fiscal Year - 1 | 5,955 | 13,326 | (4) | 77 | 8,568 | 1,049 | ||
| Fiscal Year - 2 | 3,288 | 16,370 | (131) | 848 | 6,049 | 1,060 | ||
| Fiscal Year - 3 | 112 | 17,801 | (131) | 908 | 22,908 | 1,390 | ||
| Fiscal Year - 4 | 3,196 | 14,714 | 44 | 462 | 8,072 | 1,145 | ||
| Fiscal Year - 5 | 1,335 | 15,119 | 159 | NA | 7,142 | 655 | ||
| Total Assets | ||||||||
| Latest Fiscal Quarter Prior | 104,340 | 178,287 | 10,397 | 19,319 | 103,524 | 33,396 | ||
| Latest Fiscal Quarter | 112,422 | 192,816 | 10,094 | 21,611 | 107,289 | 31,828 | ||
| Fiscal Year | 104,035 | 180,104 | 9,648 | 19,907 | 102,246 | 34,315 | ||
| Fiscal Year - 1 | 101,119 | 167,558 | 10,809 | 19,430 | 99,945 | 34,055 | ||
| Fiscal Year - 2 | 96,483 | 187,378 | 11,017 | 17,557 | 117,453 | 34,815 | ||
| Fiscal Year - 3 | 105,363 | 182,018 | 10,426 | 17,542 | 131,795 | 34,451 | ||
| Fiscal Year - 4 | 66,729 | 174,894 | 11,488 | 17,946 | 127,778 | 34,130 | ||
| Fiscal Year - 5 | 61,377 | 157,728 | 11,301 | NA | 118,370 | 35,711 | ||
| Fiscal Year - 6 | 60,651 | 152,954 | 10,983 | NA | 145,563 | NA | ||
| Common Equity | ||||||||
| Latest Fiscal Quarter Prior | 39,512 | 70,158 | 4,545 | 8,367 | 43,317 | 16,600 | ||
| Latest Fiscal Quarter | 44,719 | 79,277 | 4,472 | 8,820 | 44,330 | 15,941 | ||
| Fiscal Year | 40,786 | 71,490 | 4,319 | 8,163 | 44,046 | 16,166 | ||
| Fiscal Year - 1 | 39,143 | 68,774 | 4,768 | 8,645 | 46,667 | 16,606 | ||
| Fiscal Year - 2 | 37,037 | 76,804 | 4,842 | 8,748 | 59,342 | 16,331 | ||
| Fiscal Year - 3 | 39,268 | 74,023 | 5,152 | 8,153 | 67,655 | 26,355 | ||
| Fiscal Year - 4 | 15,622 | 63,278 | 5,655 | 7,715 | 56,598 | 26,112 | ||
| Fiscal Year - 5 | 13,127 | 59,471 | 5,804 | NA | 55,474 | 27,321 | ||
| Fiscal Year - 6 | 12,468 | 59,752 | 5,668 | NA | 78,614 | NA | ||